Cargando…
COVID-19 Vaccine-Associated Lymphadenopathy in Breast Imaging Recipients: A Review of Literature
The unpredictability of the coronavirus disease 2019 (COVID-19) pandemic has created an ongoing global healthcare crisis. Implementation of a mass vaccination program to accelerate disease control remains in progress. Although injection site soreness, fatigue, and fever are the most common adverse r...
Autores principales: | Aleman, Roxanne T, Rauch, Julia, Desai, Janvi, Chaiban, Joumana T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375123/ https://www.ncbi.nlm.nih.gov/pubmed/35974844 http://dx.doi.org/10.7759/cureus.26845 |
Ejemplares similares
-
The Evaluation of Lymphadenopathy in a Resource-Limited Setting
por: Ali, Mohammed, et al.
Publicado: (2022) -
Can Mediastinal Lymphadenopathy Signal Pericarditis, Pericardial Effusion, and Severe Disease in a COVID-19 Patient?
por: Khan, Nabeel, et al.
Publicado: (2022) -
An Unusual Case of Chronic Kidney Disease with Mediastinal Lymphadenopathy
por: Thandra, Abhishek, et al.
Publicado: (2018) -
A Case of Adalimumab-associated Pancytopenia and Reversible Lymphadenopathy
por: Walsh, Leonard T, et al.
Publicado: (2018) -
Generalized Lymphadenopathy as the First Manifestation of Systemic Lupus Erythematosus
por: Soares, Leonor, et al.
Publicado: (2022)